Additional Context: In August 2025, U.S. Health Secretary Robert F. Kennedy Jr. announced plans to defund $500 million in grants issued by the Biomedical Advanced Research Development Authority (BARDA). He cited unvalidated concerns that mRNA technology lacks effectiveness against upper respiratory viruses such as COVID‑19 and influenza.

Devex Researcher Note: The mRNA platform is uniquely suited to pandemic preparedness due to its speed of development — capable of producing vaccine candidates in days rather than months — a capability built on decades of NIH-funded research now being abandoned. This decision has implications for global health security, as the U.S. has historically led mRNA vaccine innovation that benefits populations worldwide, particularly in low- and middle-income countries vulnerable to infectious disease outbreaks.

Source: AVAC